Chong Kun Dang Holdings Corp.

KOSE:A001630 Stok Raporu

Piyasa değeri: ₩264.2b

Chong Kun Dang Holdings Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 3/6

Chong Kun Dang Holdings's earnings have been declining at an average annual rate of -12.8%, while the Pharmaceuticals industry saw earnings growing at 11.7% annually. Revenues have been growing at an average rate of 5.1% per year. Chong Kun Dang Holdings's return on equity is 5.8%, and it has net margins of 5.1%.

Anahtar bilgiler

-12.8%

Kazanç büyüme oranı

-11.6%

EPS büyüme oranı

Pharmaceuticals Sektör Büyümesi11.3%
Gelir büyüme oranı5.1%
Özkaynak getirisi5.8%
Net Marj5.1%
Son Kazanç Güncellemesi30 Jun 2024

Yakın geçmiş performans güncellemeleri

We Think That There Are Some Issues For Chong Kun Dang Holdings (KRX:001630) Beyond Its Promising Earnings

Mar 27
We Think That There Are Some Issues For Chong Kun Dang Holdings (KRX:001630) Beyond Its Promising Earnings

Chong Kun Dang Holdings's (KRX:001630) Earnings Are Growing But Is There More To The Story?

Dec 11
Chong Kun Dang Holdings's (KRX:001630) Earnings Are Growing But Is There More To The Story?

Recent updates

Benign Growth For Chong Kun Dang Holdings Corp. (KRX:001630) Underpins Its Share Price

Aug 06
Benign Growth For Chong Kun Dang Holdings Corp. (KRX:001630) Underpins Its Share Price

We Think That There Are Some Issues For Chong Kun Dang Holdings (KRX:001630) Beyond Its Promising Earnings

Mar 27
We Think That There Are Some Issues For Chong Kun Dang Holdings (KRX:001630) Beyond Its Promising Earnings

Here's Why Chong Kun Dang Holdings (KRX:001630) Has A Meaningful Debt Burden

Apr 28
Here's Why Chong Kun Dang Holdings (KRX:001630) Has A Meaningful Debt Burden

Could Chong Kun Dang Holdings Corp. (KRX:001630) Have The Makings Of Another Dividend Aristocrat?

Apr 08
Could Chong Kun Dang Holdings Corp. (KRX:001630) Have The Makings Of Another Dividend Aristocrat?

Here's Why I Think Chong Kun Dang Holdings (KRX:001630) Is An Interesting Stock

Mar 01
Here's Why I Think Chong Kun Dang Holdings (KRX:001630) Is An Interesting Stock

The Chong Kun Dang Holdings (KRX:001630) Share Price Has Gained 54% And Shareholders Are Hoping For More

Feb 14
The Chong Kun Dang Holdings (KRX:001630) Share Price Has Gained 54% And Shareholders Are Hoping For More

Is Weakness In Chong Kun Dang Holdings Corp. (KRX:001630) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Feb 01
Is Weakness In Chong Kun Dang Holdings Corp. (KRX:001630) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Chong Kun Dang Holdings (KRX:001630) Has A Pretty Healthy Balance Sheet

Jan 19
Chong Kun Dang Holdings (KRX:001630) Has A Pretty Healthy Balance Sheet

Should Chong Kun Dang Holdings Corp. (KRX:001630) Be Part Of Your Dividend Portfolio?

Jan 06
Should Chong Kun Dang Holdings Corp. (KRX:001630) Be Part Of Your Dividend Portfolio?

Do Institutions Own Chong Kun Dang Holdings Corp. (KRX:001630) Shares?

Dec 24
Do Institutions Own Chong Kun Dang Holdings Corp. (KRX:001630) Shares?

Chong Kun Dang Holdings's (KRX:001630) Earnings Are Growing But Is There More To The Story?

Dec 11
Chong Kun Dang Holdings's (KRX:001630) Earnings Are Growing But Is There More To The Story?

Here's Why I Think Chong Kun Dang Holdings (KRX:001630) Might Deserve Your Attention Today

Nov 28
Here's Why I Think Chong Kun Dang Holdings (KRX:001630) Might Deserve Your Attention Today

Gelir ve Gider Dağılımı

Chong Kun Dang Holdings nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

KOSE:A001630 Gelir, gider ve kazançlar (KRW Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 24946,08848,129357,55823,769
31 Mar 24915,18543,598347,63423,828
31 Dec 23879,78147,007327,49523,222
30 Sep 23873,67437,630334,12723,283
30 Jun 23878,98624,682355,54922,606
31 Mar 23885,80210,331368,14422,177
31 Dec 22908,9631,074395,45622,708
30 Sep 22904,215-2,042394,86822,544
30 Jun 22906,9192,295380,95621,685
31 Mar 22917,63412,605381,84221,882
31 Dec 21925,97515,993374,96920,926
30 Sep 21928,51746,247372,59023,050
30 Jun 21917,14261,134358,50722,596
31 Mar 21892,12571,524326,04520,990
31 Dec 20858,11978,676294,45120,660
30 Sep 20831,66956,693266,33417,961
30 Jun 20794,93051,594240,91617,639
31 Mar 20765,40138,289228,31317,164
31 Dec 19720,64445,029216,75016,389
30 Sep 19672,70641,007193,62213,821
30 Jun 19623,23634,037175,67812,839
31 Mar 19571,09032,726151,87212,135
31 Dec 18531,11427,457131,28011,171
30 Sep 18503,95239,462120,90110,130
30 Jun 18485,18942,582117,4519,771
31 Mar 18473,13345,658114,6269,734
31 Dec 17450,73548,009107,4389,672
30 Sep 17432,10836,805101,4849,850
30 Jun 17418,60642,34490,7029,434
31 Mar 17373,45341,45479,0187,837
31 Dec 16335,67629,43169,1506,468
30 Sep 16304,12627,36060,2484,831
30 Jun 16267,36017,30254,1453,785
31 Mar 16243,63820,46645,2503,758
31 Dec 15221,83215,20836,8693,873
30 Sep 15205,9825,09331,8172,075
30 Jun 15185,4275,26426,8401,891
31 Mar 15182,3724,22924,8441,677
31 Dec 14181,3959,46124,5861,313
30 Sep 14227,257389,68640,8587,165
30 Jun 14337,405400,74777,57116,874
31 Mar 14458,939409,768126,35220,609
31 Dec 13560,618416,161167,96026,823

Kaliteli Kazançlar: A001630 has a large one-off gain of ₩42.0B impacting its last 12 months of financial results to 30th June, 2024.

Büyüyen Kar Marjı: A001630's current net profit margins (5.1%) are higher than last year (2.8%).

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: A001630's earnings have declined by 12.8% per year over the past 5 years.

Büyüme Hızlandırma: A001630's earnings growth over the past year (95%) exceeds its 5-year average (-12.8% per year).

Kazançlar vs. Sektör: A001630 earnings growth over the past year (95%) exceeded the Pharmaceuticals industry 21.9%.

Özkaynak Getirisi

Yüksek ROE: A001630's Return on Equity (5.8%) is considered low.

Varlık Getirisi

Kullanılan Sermaye Getirisi

Geçmişte güçlü performans gösteren şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y